Cryoablation versus lumpectomy for early breast cancer
Part of Cancer, Skin clinical trials.
This trial compares two ways to remove early-stage breast tumors: freezing (cryoablation) or surgery (lumpectomy). It may help find which option works as well or better for cancer control while keeping the breast looking more natural for some people.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have early invasive breast cancer that is ER-positive and HER2-negative, grade 1 or 2
- Your tumor is T1N0M0—meaning 2 cm or smaller, no lymph node spread, and no distant spread
- If DCIS is seen, it must be under 25% and directly connected to the invasive cancer (not separate)
- You are at least 50 years old, and your Oncotype score (for eligible tumor types) is under 26
- Your armpit (axillary) lymph node check is negative on imaging or biopsy (ultrasound, sentinel node, or percutaneous node)
- You can sign consent, use local anesthesia safely, and are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares a less invasive treatment called ablation (which uses extreme cold to destroy the tumor) with standard surgery for early-stage breast cancer. It is for women aged 50 or older with a small, low-risk tumor that has not spread.
This study tests if freezing a very small early-stage breast tumor (cryoablation) can be as effective as surgery. It may be an option for people whose tumor is small enough and hasn't spread to lymph nodes or elsewhere.
This trial tests cryoablation (freezing the tumor with a needle) as a way to treat small, low-risk breast cancers without surgery. It is for women 50 or older whose cancers are hormone-receptor-positive and haven't spread to lymph nodes.
This study tests cryoablation (freezing) to treat small, early stage breast cancers that are hormone receptor positive and HER2 negative. It may be an option for postmenopausal women who want to avoid surgery.
This trial studies a type of radiation made with protons to treat only part of the breast after surgery (lumpectomy) for early-stage breast cancer. It may help control the cancer while aiming to reduce radiation to surrounding tissues.
This trial is for women aged 55 or older with very early-stage breast cancer (stage 0 or 1) who want to save their breast. It tests giving a single dose of radiation during the lumpectomy instead of weeks of daily radiation afterward.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.